Patent classifications
A61L31/044
Methods and compositions for the treatment of wounds
The methods and compositions described herein address the need in the art by providing peptides and polypeptides comprising a growth factor binding domain. In some embodiments, the peptides have an amino acid sequence that is at least 80% identical to one of SEQ ID NOS:1-7, 13-15, 49-50, or 66-70, or a fragment thereof; wherein the peptide is less than 300 amino acids in length.
THREE-DIMENSIONAL TISSUE BODY, METHOD FOR PRODUCING SAME, AND FORMATION AGENT FOR THREE-DIMENSIONAL TISSUE BODY
A method may comprises bringing cells suspended in an aqueous medium into contact with a plurality of fragmented collagen pieces and, after the cells brought into contact with the plurality of fragmented collagen pieces and the plurality of fragmented collagen pieces are concentrated, culturing the cells brought into contact with the fragmented collagen pieces, with the plurality of fragmented collagen pieces, to form a three-dimensional tissue.
BIOLOGICAL FLUID PURIFICATION WITH BIOCOMPATIBLE MEMBRANES
Disclosed are apparatus and methods for blood and other biological fluid purification using a membrane with cell containing vascular channel systems and filtration channel systems. Also disclosed are methods of making the apparatus as well as methods of making membranes.
WOUND CLOSURE DEVICES COMPRISING PROTOCATECHUIC ACID
A suture or a surgical or wound closure staple is disclosed that includes protocatechuic acid. The protocatechuic acid may be coated on, or impregnated in, the suture or wound closure staple. The suture or wound closure staple may include polypropylene, nylon, polyester, and/or braided polyester, catgut, 85/15 D,L lactide/glycolide, and/or 910 Vicryl. The protocatechuic acid may coat 25% or more of the surface of the suture or surgical staple. In embodiments, the protocatechuic acid may have a purity of 95% or greater. The protocatechuic acid may include crystalline protocatechuic acid.
Implantable pouch with segmental lamination structure, and related methods of manufacture and use
Described are implantable pouch products having a segmental lamination structure that provides an interior pocket for receiving a medical device, for example an electronic medical device such as a cardiac pacemaker or defibrillator. Also described are methods for making and using such products.
Wound anchor sterile pen
A wound anchor sterile pen (WASP), and a system and method for administering to wounds of mass casualties using multiple WASPs. This system has tactical, EMS, Mass Casualty, disaster, lay-responder and self-use in mind. It is also designed to allow tracking using RFID tags and Blockchain technology. It is a needed product for treating mass casualties in combat as well as in shooting situations such as those that have recently occurred at schools, night clubs and other large gatherings. The device can assist in stopping blood flow from wounds and give the injured person more time to obtain hospital treatment to hopefully preserve the person’s life.
SYSTEMS AND METHODS FOR AUTOMATED IMAGE RECOGNITION OF IMPLANTS AND COMPOSITIONS WITH LONG-LASTING ECHOGENICITY
Systems and methods for imaging an object that are capable of capturing an image or images of the object using an imaging modality, automatically detecting and analyzing the image or images by way of converting the image or images to at least one binary image, and analyzing the at least one binary image to extract and/or segment regions-of-interest (ROIs) from the at least one binary image. The object can be or include an implantation, occlusion, medical device, body lumen, tissue, organ, duct, and/or vessel. The imaging modality can be or include X-ray, CT, MRI, PET, and/or ultrasound, or any combination thereof. Also included are compositions of soft, implantable materials with one or more carbon-based material, nanomaterial, and/or allotrope present in an amount sufficient as an ultrasound contrast agent effective for days, months, or years and which compositions are useful in the automated imaging methods of the invention.
Methods for stabilizing collagen-containing tissue products against enzymatic degradation
Methods for producing crosslinked tissue matrices, crosslinked tissue matrices produced by such methods, as well as tissue products comprising such tissue matrices are disclosed. The methods comprise (1) dehydrating a collagen-containing tissue matrix to form a dehydrated collagen-containing tissue matrix; and (2) irradiating the dehydrated collagen-containing tissue matrix such that at least a portion of the dehydrated collagen-containing tissue matrix is crosslinked.
Three-dimensional tissue body, method for producing same, and formation agent for three-dimensional tissue body
Disclosed is a three-dimensional tissue comprising cells and collagen including endogenous collagen, wherein at least a portion of the cells is adhered to the collagen, and the content of the collagen is from 10 wt % to 90 wt % based on the three-dimensional tissue.
Biodegradable Two-Layered Matrix for Preventing Post-Surgical Adhesions
A biodegradable matrix for preventing post-surgical adhesions, in particular after soft tissue repair in abdominal surgery within the body of a mammal is disclosed. The matrix includes a top layer made of a first biocompatible polymer material and a bottom layer made of a second biocompatible polymer material. The first polymer material comprises poly(lactic acid) as a main component and the second polymer material comprises as a main component at least one polymer selected from the group consisting of poly(glycolic acid), poly(lactic acid), poly(glycolic acid-lactic acid) and mixtures thereof, wherein the poly(lactic acid)content of the first polymer material is higher than in the second polymer material, and wherein both layers are formed as porous scaffolds with the top layer being hydrophilic, having a water contact angle of less than 75°, and the bottom layer being hydrophobic, having a water contact angle of more than 90°.